MCMCB Pro
Q0515

Q0515Injection, sermorelin acetate, 1 microgram

HCPCSActiveBETOS O1E

Q0515 is a HCPCS Level II code for injection, sermorelin acetate, 1 microgram. It belongs to the Temporary Codes section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of Q0515 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Drug discontinued
outpatient
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Drug discontinued

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for Q0515

Long descriptor
Injection, sermorelin acetate, 1 microgram

The official wording. This is what the code means.

Short descriptor
Sermorelin acetate injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2006

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to Q0515

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If Q0515 is not quite right, the correct code is very often within a few positions of it.

  • Q0507Miscellaneous supply or accessory for use with an external ventricular assist device
  • Q0508Miscellaneous supply or accessory for use with an implanted ventricular assist device
  • Q0509Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
  • Q0510Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
  • Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
  • Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
  • Q0513Pharmacy dispensing fee for inhalation drug(s); per 30 days
  • Q0514Pharmacy dispensing fee for inhalation drug(s); per 90 days
  • Q0516Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-daysterminated
  • Q0517Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-daysterminated
  • Q0518Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-daysterminated
  • Q0519Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-daysterminated
  • Q0520Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-daysterminated
  • Q0521Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
  • Q1004New technology intraocular lens category 4 as defined in federal register notice
  • Q1005New technology intraocular lens category 5 as defined in federal register notice

Questions about Q0515

What is HCPCS code Q0515?

Q0515 is a HCPCS Level II code for injection, sermorelin acetate, 1 microgram. It sits in the Temporary Codes section.

Does Medicare cover Q0515?

The CMS HCPCS file marks Q0515 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is Q0515 paid under the physician fee schedule?

Q0515 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026